Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Manisha Padmakumar"'
Autor:
Manisha Padmakumar, Steven Biesmans, Jorge S. Valadas, Jan R. Detrez, Gaëlle Gillet, Priscillia Bresler, Marie-Laure Clénet, Irena Kadiu
Publikováno v:
Frontiers in Drug Discovery, Vol 3 (2023)
Neuroscience drug discovery has faced significant challenges due to restricted access to relevant human cell models and limited translatability of existing preclinical findings to human pathophysiology. Induced pluripotent stem cells (iPSCs) have eme
Externí odkaz:
https://doaj.org/article/4e10a82de23d46c7890710e9bc03d4d9
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 3, Iss 4, Pp 566-577 (2019)
Abstract Autism spectrum disorder (ASD) is a clinically heterogeneous neurodevelopmental disorder that is caused by gene‐environment interactions. To improve its diagnosis and treatment, numerous efforts have been undertaken to identify reliable bi
Externí odkaz:
https://doaj.org/article/7cf875eacf8e4a6285b3871d84c30ed2
Autor:
Manisha Padmakumar, Jaak Jaeken, Vincent Ramaekers, Lieven Lagae, Daniel Greene, Chantal Thys, Chris Van Geet, NIHR BioResource, Kathleen Stirrups, Kate Downes, Ernest Turro, Kathleen Freson
Publikováno v:
JIMD Reports, Vol 47, Iss 1, Pp 9-16 (2019)
Abstract Background Brain monoamine vesicular transport disease is an infantile onset neurodevelopmental disorder caused by variants in SLC18A2, which codes for the vesicular monoamine transporter 2 (VMAT2) protein, involved in the transport of monoa
Externí odkaz:
https://doaj.org/article/fc61d66386ba4d82840c3f4a32dfd91f
Publikováno v:
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis, Vol 3, Iss 4, Pp 566-577 (2019)
Research and Practice in Thrombosis and Haemostasis, Vol 3, Iss 4, Pp 566-577 (2019)
Autism spectrum disorder (ASD) is a clinically heterogeneous neurodevelopmental disorder that is caused by gene-environment interactions. To improve its diagnosis and treatment, numerous efforts have been undertaken to identify reliable biomarkers fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96772a5028d910422fd939ace48b6346
http://europepmc.org/articles/PMC6781926
http://europepmc.org/articles/PMC6781926
Autor:
Nihr BioResource, Jaak Jaeken, Lieven Lagae, Ernest Turro, Kate Downes, Kathleen Stirrups, Daniel Greene, Manisha Padmakumar, Chantal Thys, Kathleen Freson, Vincent Ramaekers, Chris Van Geet
Publikováno v:
JIMD Reports
JIMD Reports, Vol 47, Iss 1, Pp 9-16 (2019)
JIMD Reports, Vol 47, Iss 1, Pp 9-16 (2019)
BACKGROUND: Brain monoamine vesicular transport disease is an infantile onset neurodevelopmental disorder caused by variants in SLC18A2, which codes for the vesicular monoamine transporter 2 (VMAT2) protein, involved in the transport of monoamines in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb3b08241cafc99cf9adb6e02286386c
http://europepmc.org/articles/PMC6498820
http://europepmc.org/articles/PMC6498820